FDA inspection
Nanhai Beisha Pharmaceutical Co., Ltd.: FDA inspection ending Sep 19, 2025
FDA inspection 1283814 · Voluntary Action Indicated (VAI) · Nanhai, Foshan
Key facts
| Inspection ID | 1283814 |
|---|---|
| Firm | Nanhai Beisha Pharmaceutical Co., Ltd. |
| FEI number | 3003857764 |
| Address | No. 21, Shaluo Industrial Zone, Beisha Village, Lishui Town |
| City | Nanhai, Foshan |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Sep 19, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data